Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Yamanouchi claims antidiabetic agents

May 17, 1996

rhIL-11 reduces need for platelet transfusions in chemotherapy recipients

May 17, 1996

Positive preliminary results announced for CholestaGel phase IIa study

May 17, 1996

FO-2546F: ACAT inhibitor from Albophoma yamanashiensis

May 17, 1996

Creative Biomolecules, Stryker extend OP-1 agreement

May 17, 1996

Estraderm MX launched in U.K.

May 10, 1996

Estring approved for marketing in U.S.

May 10, 1996

Muse safety and efficacy reported at urology meeting

May 10, 1996

Sildenafil demonstrates efficacy in erectile dysfunction Rx

May 10, 1996

AI-401 progresses to phase II

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...